Interpretation of the FDA Final Rule of Electronic Records and Electronic Signatures (21 CFR Part 11). This policy defines the company-wide interpretation of the regulations of Part 11 and how they would specifically apply (or not apply) for the firm.
Customer Reviews:
There are yet no reviews for this product. Please log in to write a review.
You may also be interested in this/these product(s):
Interpretation of 21 CFR Part 11
